The H. Pylori Test Market is witnessing steady growth due to the increasing prevalence of Helicobacter pylori (H. pylori) infections worldwide and the rising demand for accurate diagnostic tests. H. pylori is a bacterium that infects the stomach lining and is associated with various gastrointestinal disorders, including peptic ulcers and gastric cancer.
Key drivers of market growth include growing awareness about the link between H. pylori infection and gastrointestinal diseases, leading to increased screening and testing among at-risk populations. Additionally, advancements in diagnostic technology, such as rapid antigen tests, molecular assays, and urea breath tests, enhance the accuracy and efficiency of H. pylori detection, driving market expansion.
The Pylori Bacteria Test market is growing due to the prevalence of H. pylori infections worldwide. These tests detect the presence of the bacteria in the stomach, aiding in the diagnosis and management of gastrointestinal conditions. With rising awareness of H. pylori-related health risks, the market for pylori bacteria tests is expanding steadily.
The market offers a variety of H. pylori tests, including invasive tests such as endoscopy with biopsy and non-invasive tests such as stool antigen tests and serology tests, catering to different clinical scenarios and patient preferences. Moreover, the availability of point-of-care testing kits allows for rapid and convenient diagnosis of H. pylori infection in primary care settings.
The market for H. Pylori (Helicobacter Pylori) tests was estimated to be worth USD 2.9 billion in 2022. The market for H. Pylori (Helicobacter Pylori) tests is expected to expand at a compound annual growth rate (CAGR) of 5.70% between 2023 and 2032, from an estimated USD 3.06 billion in 2023 to USD 4.78 billion by 2032.
H. Pylori (Helicobacter Pylori) Test Market – Segments
The report is segmented into four dynamics;
By Test Type: Non-Endoscopic and Endoscopic.
By Technology: Immunoassays, Point-of-Care (POC), Molecular Diagnostics, and others.
By End-User: Hospitals & Clinics, Diagnostics Laboratories, and others.
By Regions: Americas, Europe, Asia Pacific, and the Rest-of-the-World.
Helicobacter Pylori Test Market – Regional Analysis
North America dominates the global H. Pylori test market. The largest market share attributes well-developed healthcare sectors and a huge patient population. Besides, the rising numbers of diagnostic companies in the region impact the growth of helicobacter pylori market in North America. Additionally, increasing numbers of clinical researches led by funding from the public & private organizations are fostering the H. Pylori test market in the region.
Moreover, the strong presence of major diagnostic companies such as Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Inc., Abbott Laboratories, and Quest Diagnostics Incorporated, Cardinal Health, enables early adoption of advanced diagnostic products. Also, the changing lifestyle and high per capita healthcare expenditure of demographics are fuelling the growth of the regional market. The North American helicobacter pylori market is estimated to retain its leading position in the global market throughout the review period.
Europe stands second in the global Helicobacter Pylori Test market. Market growth is driven by the availability of funds for research and a vast patient population. Among the two major European segments, Western Europe is leading the H. Pylori Test market, while Eastern Europe is the fastest-growing market in the region.
The Asia pacific helicobacter pylori test market is growing rapidly. Factors such as increasing advances in medical technologies and the fast-growing healthcare sector in the region are propelling the growth of the market. Also, growing government support for R&D boosts the growth H. Pylori Test market in the region. Besides, the continually rising population and poor sanitation conditions, alongside the rising burden of the H. pylori infection in the region, drive the market growth.
Highly populated countries such as China and India, with the availability of low-cost diagnostic tests, contribute to the regional market growth majorly. The APAC H. Pylori Test market is projected to demonstrate a lucrative market growth throughout the forecast period.
H. Pylori Test Market – Competitive Analysis
Highly competitive, the H. Pylori Test market appears fragmented due to the presence of several well-established players. To gain a larger competitive share, these players incorporate strategies such as mergers & acquisitions, collaboration, expansion, and product launch. Players invest substantially in R&D and clinical trials to develop tests that can give an accurate diagnosis of the infection.
They increase R&D to develop breakthrough drugs and therapeutic approaches that can improve patients' quality of life. Companies also focus on areas with high unmet medical needs and require further innovation despite the progress that has been made.
H. Pylori Test companies comprise Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Hoffmann-La Roche Ltd (Switzerland), Quest Diagnostics Incorporated (US), Meridian Bioscience (US), CorisBioconcept SPRL (Belgium), Cardinal Health (US), QIAGEN (Germany), Abbott Laboratories (US), and Biohit Oyj (Finland).
For more information visit at MarketResearchFuture
